0001213900-22-030914.txt : 20220602 0001213900-22-030914.hdr.sgml : 20220602 20220602145027 ACCESSION NUMBER: 0001213900-22-030914 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220602 FILED AS OF DATE: 20220602 DATE AS OF CHANGE: 20220602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ADAMS ERIC A CENTRAL INDEX KEY: 0001817882 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39685 FILM NUMBER: 22990366 MAIL ADDRESS: STREET 1: C/O INMED PHARMACEUTICALS INC. STREET 2: SUITE 310 - 815 HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 4 1 ownership.xml X0306 4 2022-06-02 0 0001728328 InMed Pharmaceuticals Inc. INM 0001817882 ADAMS ERIC A C/O INMED PHARMACEUTICALS INC. 310-815 WEST HASTINGS ST. VANCOUVER A1 V6C1B4 BRITISH COLUMBIA, CANADA 1 1 0 0 President & CEO Employee Stock Option (Expiration) 11.75 2022-06-02 4 H 0 13636 0.00 D 2017-06-02 2022-06-02 Common shares 13636 337576 D Converted from the Canadian dollar exercise price of C$14.85 using an exchange rate of C$1.2639 = $US1.00 /s/ Brenda Edwards, attorney-in-fact for Mr. Eric A Adams 2022-06-02